The Senate health committee sets a vote for next week on Dr. Heidi Overton’s nomination to become commissioner of the Food and Drug Administration (FDA), though her approval is not assured. The committee schedules the vote for Nov. 18, according to a committee press release referenced by both outlets.

Both reports focus on the procedural next step in Overton’s confirmation process. The Hill emphasizes that key momentum may still be uncertain as lawmakers have not signaled full support. STAT News likewise highlights that GOP lawmakers have not yet expressed support for Overton, framing the scheduled vote alongside the lack of clear backing. Together, the coverage underscores that the nomination advances to committee consideration, while support remains a central question before any further Senate action.